•
Jun 30, 2020

The Joint Q2 2020 Earnings Report

The Joint Corp.'s financial performance was driven by strong clinic operations, clinic openings and franchise license sales.

Key Takeaways

The Joint Corp. reported a revenue increase of 13% compared to Q2 2019, driven by a greater number of clinics. The company's net income was $116,000, or $0.01 per diluted share.

Revenue increased by 13% compared to Q2 2019, reaching $12.6 million.

The company increased total clinic count to 539, opening 13 clinics in Q2 2020.

The Joint Corp. sold 11 franchise licenses in Q2 2020.

Net income was $116,000, or $0.01 per diluted share.

Total Revenue
$12.6M
Previous year: $11.2M
+12.7%
EPS
$0.01
Previous year: $0.03
-66.7%
Franchise Licenses Sold
11
Previous year: 16
-31.3%
Gross Profit
$11.2M
Previous year: $9.87M
+13.7%
Cash and Equivalents
$14.6M
Previous year: $9.49M
+53.9%
Free Cash Flow
$839K
Previous year: $1.34M
-37.2%
Total Assets
$49.6M
Previous year: $36.5M
+36.0%

The Joint

The Joint

Forward Guidance

The company withdrew its 2020 financial and clinic opening guidance due to uncertainties related to the COVID-19 pandemic and is not providing an update at this time.